Darden James Matthew's Form 4/A amendment
AmendedGlobe Life Inc. (GL) · filed Nov 7, 2023
- Accession no.
- 0001062993-23-020271
- Filed
- Nov 7, 2023
- Trade date
- Nov 3, 2023
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
- Original filed
- Nov 6, 2023
This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $1.00M. It was filed 4 days after the trade.
This amendment replaces 0001062993-23-020222 (filed Nov 6, 2023).
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Darden James MatthewCIK 0001624335 | Director, Officer (Co-Chairman & CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 3, 2023 | Common Stock | MOption exerciseAcquired | +9,551 | $77.26 | +$737,910.26 | 34,753.92 | Direct | |
| Nov 3, 2023 | Common Stock | SSaleDisposed | −8,551 | $116.98 | −$1,000,295.98 | 26,202.92 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 3, 2023 | Common Stock | MOption exerciseDisposed | −9,551 | $0.00 | $0 | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Sales at prices ranging from $116.69 per share to $117.175 per share.
- F2
Reporting person will provide full information regarding the number of shares sold at each separate price upon request by the SEC staff, the issuer or any security holder of the issuer.
- F3
Shares in unitized fund in employee benefit plan - estimated conversion of $ balance to shares using $117.16 per share.
- F4
Amended to include 132.794 shares acquired through a brokerage dividend reinvestment plan since date of last report.